Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
CAFTA Damage Report: Despite Significant Job Losses from NAFTA, Rep. Henry Cuellar (D-Texas) Casts a Deciding Vote for Expansion of NAFTA to Central America August 29, 2005
ISDS Case Study: RDC v. Guatemala: CAFTA Investor-State Ruling: Tribunal Ignores CAFTA Annex, Cites Another Tribunal to Rule against Guatemala July 19, 2012